Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$774M |
| 2 |
Intuitive Surgical
ISRG
|
+$654M |
| 3 |
S&P Global
SPGI
|
+$464M |
| 4 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$326M |
| 5 |
CELG
Celgene Corp
CELG
|
+$243M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FedEx
FDX
|
+$591M |
| 2 |
Broadcom
AVGO
|
+$550M |
| 3 |
Monster Beverage
MNST
|
+$408M |
| 4 |
Booking.com
BKNG
|
+$377M |
| 5 |
McDonald's
MCD
|
+$371M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.27% |
| 2 | Consumer Discretionary | 16.23% |
| 3 | Healthcare | 15.49% |
| 4 | Financials | 12.97% |
| 5 | Communication Services | 11.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
Walt Disney
DIS
$167B
| $4.41M | ﹤0.01% |
37,735
-619
| -2% | -$68.9K |
|
502
Mohawk Industries
MHK
$7.52B
| $3.91M | ﹤0.01% |
22,305
-214,409
| -91% | -$42.1M |
|
503
Republic Services
RSG
$64.7B
| $3.82M | ﹤0.01% |
+52,515
| New | +$3.8M |
|
504
Inspire Medical Systems
INSP
$1.45B
| $3.79M | ﹤0.01% |
89,980
+674
| +0.8% | +$31.6K |
|
|
EB
505
DELISTED
Eventbrite
EB
| $3.73M | ﹤0.01% |
+98,115
| New | +$3.55M |
|
506
Protagonist Therapeutics
PTGX
$8.76B
| $3.6M | ﹤0.01% |
+349,697
| New | +$3.01M |
|
|
AUTL
507
Autolus Therapeutics
AUTL
$405M
| $3.6M | ﹤0.01% |
119,190
+947
| +0.8% | +$25.6K |
|
|
SBT
508
DELISTED
Sterling Bancorp, Inc. Common Stock
SBT
| $3.22M | ﹤0.01% |
284,969
| – | – |
|
509
RenaissanceRe
RNR
$13.3B
| $3.16M | ﹤0.01% |
23,659
| – | – |
|
510
State Street SPDR S&P Metals & Mining ETF
XME
$3.88B
| $3.13M | ﹤0.01% |
91,638
-30,069
| -25% | -$1.05M |
|
511
Arbutus Biopharma
ABUS
$845M
| $2.55M | ﹤0.01% |
+269,699
| New | +$2.68M |
|
512
HCA Healthcare
HCA
$86.8B
| $2.53M | ﹤0.01% |
18,202
-3,541
| -16% | -$441K |
|
513
Fortinet
FTNT
$118B
| $2.41M | ﹤0.01% |
130,395
-1,194,910
| -90% | -$18.3M |
|
|
AMR
514
DELISTED
Alta Mesa Resources Inc
AMR
| $2.39M | ﹤0.01% |
572,359
-55,463
| -9% | -$304K |
|
515
VF Corp
VFC
$5.68B
| $2.28M | ﹤0.01% |
25,909
-3,255
| -11% | -$278K |
|
516
LyondellBasell Industries
LYB
$20.1B
| $2.27M | ﹤0.01% |
22,121
-3,570
| -14% | -$390K |
|
517
Sutro Biopharma
STRO
$406M
| $2.25M | ﹤0.01% |
+15,000
| New | +$2.27M |
|
|
FDC
518
DELISTED
First Data Corporation
FDC
| $2.18M | ﹤0.01% |
88,979
+34,096
| +62% | +$822K |
|
|
DFS
519
DELISTED
Discover Financial Services
DFS
| $2.15M | ﹤0.01% |
28,191
-2,245
| -7% | -$169K |
|
520
RBC Bearings
RBC
$17.4B
| $2.15M | ﹤0.01% |
14,317
-182
| -1% | -$26.2K |
|
|
GWB
521
DELISTED
Great Western Bancorp, Inc.
GWB
| $2.14M | ﹤0.01% |
+50,677
| New | +$2.16M |
|
522
FTI Consulting
FCN
$4.43B
| $2.06M | ﹤0.01% |
28,202
-5,772
| -17% | -$425K |
|
|
K
523
DELISTED
Kellanova
K
| $2.04M | ﹤0.01% |
+30,960
| New | +$2.09M |
|
524
Omnicom Group
OMC
$21.5B
| $1.99M | ﹤0.01% |
+29,270
| New | +$2.05M |
|
525
Motorola Solutions
MSI
$72.5B
| $1.99M | ﹤0.01% |
+15,276
| New | +$1.89M |
|
Similar funds
Jennison Associates's Q3 2018 Portfolio in Review
As of Q3 2018, Jennison Associates held 739 positions worth $109B, up 5.9% from $103B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Jennison Associates's Q3 2018 filing shows 86 new, 214 increased, 352 reduced and 81 closed positions. Its largest new stake was Tiffany & Co.: 1,169,094 shares worth $151M. The largest sale was FedEx, an estimated $591M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Jennison Associates's largest Q3 2018 buy was Tiffany & Co.: 1,169,094 shares worth $151M.
- Jennison Associates added most to AstraZeneca in Q3 2018, an estimated $774M increase.
- Jennison Associates's biggest Q3 2018 reduction was FedEx, cutting an estimated $591M.
- Jennison Associates fully exited Cheniere Energy Partners LP Holdings LLC in Q3 2018, selling an estimated $134M.
- Jennison Associates's ten largest holdings make up 30% of its $109B portfolio in Q3 2018.
- Jennison Associates opened 86 new positions and closed 81 in Q3 2018.
- Jennison Associates's portfolio value rose 5.9% quarter-over-quarter to $109B.
Based on Jennison Associates's 13F filing for Q3 2018, filed 8 Nov 2018.